Armata Pharmaceuticals, Inc. (ARMP) — Stock Score Summary

Armata Pharmaceuticals, Inc. (ARMP) has a MoatMap StockRank of 29/100 based on Quality (11/100), Value (46/100), and Momentum (59/100) factor scores. The current signal is SELL. Armata Pharmaceuticals is a micro-cap, clinical-stage biotech company with no approved products and continuous cash burn. It fails all quality and financial filters.

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for antibiotic-resistant bacterial infections. The company leverages its proprietary phage-specific platform and state-of-the-art manufacturing facility to target high-unmet-need respiratory and systemic infections. Armata operates as a niche pioneer in the phage therapy sector, backed by strategic partnerships and a robust IP portfolio.

Key Financial Metrics

Price$7.78
Market Cap$298M
P/E (Forward)-4.90
Price/Book-0.90
Return on Invested Capital-231.4%
Gross Margin-202.1%
Operating Margin-1113.4%
Revenue Growth60.7%
Free Cash Flow$-26M

Armata Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Armata Pharmaceuticals, Inc.’s (ARMP) StockRank?
MoatMap’s StockRank for Armata Pharmaceuticals, Inc. (ARMP) is 29/100, with a Sell signal. It is a composite of Quality (11), Value (46), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Armata Pharmaceuticals, Inc. have an economic moat?
Armata Pharmaceuticals, Inc. (ARMP) has a Quality factor score of 11/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Armata Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Armata Pharmaceuticals, Inc. (ARMP) is Sell, based on a StockRank of 29/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Armata Pharmaceuticals, Inc. in?
Armata Pharmaceuticals, Inc. (ARMP) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksARMP deep dive reportAI ChampionsHow we score stocksSense-check another stock